BOSTON--(BUSINESS WIRE)--Ancora Heart, Inc., a company developing a completely transcatheter device-based therapy to address heart failure (HF), today announced that patients treated with the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback